Three Congressional Flu Hearings Planned For Next Week
This article was originally published in The Pink Sheet Daily
Executive Summary
The Senate Special Committee on Aging and the House Energy & Commerce and Government Reform Committees will hold hearings to discuss flu vaccine supply. FDA Acting Commissioner Lester Crawford and NIAID Director Anthony Fauci are expected to be among the witnesses.
You may also be interested in...
FDA's Cure For The Flu: Orphan Drug-Like Incentives, Tissue-Based Production
The agency plans to request congressional action on influenza vaccine incentives during three hearings on the flu vaccine shortage. FDA, in cooperation with U.K. regulatory officials, will determine in January whether Chiron will be able to manufacture Fluvirin at the company’s Liverpool facility for the 2005-06 flu season.
Chiron Halts Menjugate Meningococcal Vaccine Program After Pivotal Trials
Phase III trials were “successfully concluded,” but there are no plans to file a BLA for the meningococcal C conjugate vaccine due to limited commercial viability, Chiron says. The company plans to begin Phase III trials for its quadravalent meningococcal vaccine in 2005.
FDA's Cure For The Flu: Orphan Drug-Like Incentives, Tissue-Based Production
The agency plans to request congressional action on influenza vaccine incentives during three hearings on the flu vaccine shortage. FDA, in cooperation with U.K. regulatory officials, will determine in January whether Chiron will be able to manufacture Fluvirin at the company’s Liverpool facility for the 2005-06 flu season.